Revvity ٩ مايو ٢٠٢٦ Revvity Inc. stock (US76155R1086): Barclays lifts price target as Q1 beats estimates - AD HOC NEWS
Revvity ٦ مايو ٢٠٢٦ Revvity tops Q1 estimates and unveils plans to exit China immunodiagnostics - Indian Pharma Post
Revvity ٥ مايو ٢٠٢٦ Revvity Outperforms in Q1 2026 Driven by Pharma Rebound and Strategic Portfolio Shifts - Lab Manager
Revvity ٢٠ أبريل ٢٠٢٦ A Look At Revvity (RVTY) Valuation As Mixed Recent Returns Contrast With Undervaluation Narrative - Yahoo Finance
Revvity ١٩ أبريل ٢٠٢٦ The Bull Case For Revvity (RVTY) Could Change Following Its New AI-Enabled Oncology Platform Push - simplywall.st
Revvity ١٧ أبريل ٢٠٢٦ Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026 - BioSpace
Revvity ٩ أبريل ٢٠٢٦ Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows - Business Wire
Revvity ٦ أبريل ٢٠٢٦ Revvity Gains on Diagnostics Strength, Faces China Headwinds - Zacks Investment Research
Revvity ١٣ يناير ٢٠٢٦ Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads. - Barron's
Revvity ١٢ يناير ٢٠٢٦ Revvity, Lilly Expand Access to Federated AI Drug Discovery Models - Lab Manager